Skip to content

Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus

Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01471301
Enrollment
120
Registered
2011-11-15
Start date
2011-06-30
Completion date
Unknown
Last updated
2011-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic

Keywords

systemic lupus erythematosus, rheumatoid arthritis

Brief summary

The purpose of this study is to evaluate ultrasound hands in patients with systemic lupus erythematosus.

Detailed description

Introduction: The systemic lupus erythematosus (SLE) is a disease with a common articular involvement. Approximately 1-2% of patients with SLE have joint inflammation similar to rheumatoid arthritis (RA). There are no well-designed studies of lupus arthropathy. Primary objectives: To evaluate the ultrasonographic examination of the hands in patients with systemic lupus erythematosus and make its correlation with examination of patients with rheumatoid arthritis (RA) established and with clinical, serological, radiological and functional. Material and methods: a transversal study will be carried out on patients diagnosed with with SLE and RA. Clinical Instruments: count of swollen and tender joints, visual analogue scale (VAS) for pain (0-10 cm), edema and for disease activity; disease activity (DAS 28 and SLEDAI), hand grip strength and pinch (Jamar dynamometer and Preston Pinch Gauge); functional questionnaires (HAQ and DASH). It will be observed the presence of puffy hands, Raynaud's phenomenon and presence of autoantibodies. Radiographic instruments: evaluation of radiographs of hands and wrists according to the Sharp score modified by van der Heijde. Ultrasonographic Instruments (quantitative and semi-quantitative measures): synovial hyperplasia, synovial blood flow (Power Doppler), bone erosions and cartilage. The joints that will be evaluated: radiocarpal, distal radioulnar, first to fifth metacarpophalangeal and proximal interphalangeal. Ultrasonographic interobserver reproducibility will be carried out in 10% of the patients. All the examinators will be blind for each other findings. Rheumatoid factor and anti-CCP will be investigated in RA patients. Statistical significance will be set at 5%.

Interventions

None listed

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* age between 18 and 60 years; * female and male; * patients with SLE, according to the revised classification criteria of the ACR (Arthritis Rheum, 1997) with current or previous joint activity (arthritis or arthralgia; * patients with established RA according to ACR classification criteria (Arthritis Rheum, 1988)

Exclusion criteria

* changing the dose or drug-based immunosuppression in the last 3 months. * corticosteroid pulse therapy in the last 30 days; * infiltration with corticosteroids at hand in the last 3 months; * previous surgery in the joints studied; * irreducible deformity of the joints studied; * overlap with other joint diseases or collagen; * chiropractic diabetic; * hypothyroidism

Countries

Brazil

Contacts

Primary ContactAna Leticia Pirozzi Buosi
ana_buosi@yahoo.com.br551181352131

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026